These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 17172879)

  • 41. Implantable cardioverter-defibrillator infection due to Scedosporium apiospermum.
    Sarvat B; Sarria JC
    J Infect; 2007 Oct; 55(4):e109-13. PubMed ID: 17761293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Management of cardiac implantable electronic device infections: the challenges of understanding the scope of the problem and its associated mortality.
    Tarakji KG; Wilkoff BL
    Expert Rev Cardiovasc Ther; 2013 May; 11(5):607-16. PubMed ID: 23621142
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lead-associated endocarditis: the important role of methicillin-resistant Staphylococcus aureus.
    Greenspon AJ; Rhim ES; Mark G; Desimone J; Ho RT
    Pacing Clin Electrophysiol; 2008 May; 31(5):548-53. PubMed ID: 18439167
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices.
    Lin G; Rea RF; Hammill SC; Hayes DL; Brady PA
    Heart; 2008 Feb; 94(2):186-90. PubMed ID: 17761506
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Complication risk with pulse generator change: implications when reacting to a device advisory or recall.
    Kapa S; Hyberger L; Rea RF; Hayes DL
    Pacing Clin Electrophysiol; 2007 Jun; 30(6):730-3. PubMed ID: 17547604
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibiotic-eluting medical devices for various applications.
    Zilberman M; Elsner JJ
    J Control Release; 2008 Sep; 130(3):202-15. PubMed ID: 18687500
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates.
    Zimpfer D; Zrunek P; Roethy W; Czerny M; Schima H; Huber L; Grimm M; Rajek A; Wolner E; Wieselthaler G
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):689-95. PubMed ID: 17320566
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current concepts in the diagnosis and management of left ventricular assist device infections.
    Nienaber J; Wilhelm MP; Sohail MR
    Expert Rev Anti Infect Ther; 2013 Feb; 11(2):201-10. PubMed ID: 23409825
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Accuracy of swabs, tissue specimens, and lead samples in diagnosis of cardiac rhythm management device infections.
    Golzio PG; Vinci M; Anselmino M; Comoglio C; Rinaldi M; Trevi GP; Bongiorni MG
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S76-80. PubMed ID: 19250117
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A case of electrodeinduced endocarditis].
    Shevchenko IuL; Stonogin AV; Popov LV; Ivashkin VT; Bokeriia OA; Drapkina OM; Budaeva AK
    Klin Med (Mosk); 2005; 83(5):66-8. PubMed ID: 15984588
    [No Abstract]   [Full Text] [Related]  

  • 51. Electrophysiological interactions between implantable cardioverter defibrillators and left ventricular assist device.
    Maffè S; Perucca A; Signorotti F; Pistono M; Paffoni P; Parravicini U; Dellavesa P; Cucchi L; Paino AM; Zenone F; Pardo NF; Bielli M; Zanetta M
    Int J Cardiol; 2010 Dec; 145(3):620-3. PubMed ID: 20965592
    [No Abstract]   [Full Text] [Related]  

  • 52. Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II).
    Andersen M; Videbaek R; Boesgaard S; Sander K; Hansen PB; Gustafsson F
    J Heart Lung Transplant; 2009 Jul; 28(7):733-5. PubMed ID: 19560703
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Implantable defibrillator with left ventricular assist device compatibility.
    Oswald H; Klein G; Strüber M; Gardiwal A
    Interact Cardiovasc Thorac Surg; 2009 May; 8(5):579-80. PubMed ID: 19223309
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Infections of cardiac implantable electronic devices: Epidemiology, classification, treatment, and prognosis.
    Sławiński G; Lewicka E; Kempa M; Budrejko S; Raczak G
    Adv Clin Exp Med; 2019 Feb; 28(2):263-270. PubMed ID: 30048058
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ruptured Intracranial Mycotic Aneurysm in Infective Endocarditis With Left Ventricular Assist Device and Implantable Cardiac Defibrillator Device: A Clinical Course.
    Voruganti D; Gajurel K; Bhama JK; Cotarlan V
    Transplant Proc; 2018 Dec; 50(10):4064-4066. PubMed ID: 30577316
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Left ventricular device as destination therapy: are we there yet?
    Badiwala MV; Rao V
    Curr Opin Cardiol; 2009 Mar; 24(2):184-9. PubMed ID: 19532106
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.
    Patel ND; Weiss ES; Schaffer J; Ullrich SL; Rivard DC; Shah AS; Russell SD; Conte JV
    Ann Thorac Surg; 2008 Sep; 86(3):832-40; discussion 832-40. PubMed ID: 18721570
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Undertreatment and overtreatment of patients with infected antiarrhythmic implantable devices.
    Molina JE
    Ann Thorac Surg; 1997 Feb; 63(2):504-9. PubMed ID: 9033328
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Infections of intracardiac devices.
    Karchmer AW; Longworth DL
    Infect Dis Clin North Am; 2002 Jun; 16(2):477-505, xii. PubMed ID: 12092483
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiovascular implantable electrophysiological device-related infections: a review.
    Gould PA; Gula LJ; Yee R; Skanes AC; Klein GJ; Krahn AD
    Curr Opin Cardiol; 2011 Jan; 26(1):6-11. PubMed ID: 21076288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.